社区医疗系统多学科药物基因组学门诊的实施
本文描述了在一个已建立的社区医学遗传学项目框架内,开发并实施多学科药物基因组学门诊的过程。Northshore University HealthSystem于2015年初建立了由医学遗传学家、药师、执业护士和遗传咨询师组成的药物基因组学门诊,确定了五个关键项目要素,并采用标准化工作流程进行患者诊疗。结论认为,提供基因分型及相关服务的多学科门诊可促进药物基因组学融入临床护理,并满足精准医学早期采用者的需求。
要点
- 多学科团队包括医学遗传学家、药师、执业护士和遗传咨询师。
- 关键项目要素包括可计费服务提供者、用药和家族史记录流程、结果解读人员等。
- 药师在解释药物基因组学结果方面具有专业优势。
核心结论
- 多学科药物基因组学门诊可促进药物基因组学融入临床护理,并满足精准医学早期采用者的需求。
研究设计与样本
- 本文描述了在社区医疗系统内建立多学科药物基因组学门诊的开发与实施过程,团队包括医学遗传学家、药师、执业护士和遗传咨询师。
主要发现
- 团队确定了五个关键项目要素:可计费服务提供者、用药和家族史记录流程、结果解读人员、讨论检测风险效益局限性的人员、结果报告机制。
- 药师被认为最适合提供遗传检测结果的专家解读。
- 患者就诊通常包括两次一小时的访视,第一次获取药物基因组学相关用药和家族史、解释检测风险效益并采集样本,第二次提供检测结果和循证药物治疗推荐。
临床怎么用
- 药师可参与药物基因组学门诊,负责解读遗传检测结果并提供循证药物治疗推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical genetics program are described. SUMMARY: Pharmacogenomics is an important component of precision medicine that holds considerable promise for pharmacotherapy optimization. As part of the development of a health system-wide integrated pharmacogenomics program, in early 2015 Northshore University Health-System established a pharmacogenomics clinic run by a multidisciplinary team including a medical geneticist, a pharmacist, a nurse practitioner, and genetic counselors. The team identified five key program elements: (1) a billable-service provider, (2) a process for documentation of relevant medication and family histories, (3) personnel with the knowledge required to interpret pharmacogenomic results, (4) personnel to discuss risks, benefits, and limitations of pharmacogenomic testing, and (5) a mechanism for reporting results. The most important program component is expert interpretation of genetic test results to provide clinically useful information; pharmacists are well positioned to provide that expertise. At the Northshore University HealthSystem pharmacogenomics clinic, patient encounters typically entail two one-hour visits and follow a standardized workflow. At the first visit, pharmacogenomics-focused medication and family histories are obtained, risks and benefits of genetic testing are explained, and a test sample is collected; at the second visit, test results are provided along with evidence-based pharmacotherapy recommendations. CONCLUSION: A multidisciplinary clinic providing genotyping and related services can facilitate the integration of pharmacogenomics into clinical care and meet the needs of early adopters of precision medicine.
引用
- Dunnenberger HM, Biszewski M, Bell GC, et al. Implementation of a multidisciplinary pharmacogenomics clinic in a community health system. Am J Health Syst Pharm. 2016. PMID: 27864203
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。